Owkin welcomes leading immuno-oncology professor as Chief Medical Officer
Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data Science today,
Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data Science today,
Non-profit marks Rare Disease Day by highlighting a key resource to advance rare disease research
Studies demonstrate that approx. 1 in 3 patients with renal denervation do not have a meaningful drop in Blood Pressure
Northeast Delta Human Services Authority (NEDHSA) is set to unveil a Prescription Drug Takeback Box in Jonesboro on Friday, February 18.
Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech
Post Views: 239 CS Analytical Laboratory, the world’s only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, is excited to announce that Chief Scientific Officer Brandon Zurawlow will lead the CCI training course at the Industrial Production Processes (IPP) Ltd Container Closure…
Post Views: 273 The Rett Syndrome Research Trust (RSRT) has joined the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (AMP®BGTC), a public-private collaboration led by the Foundation for the National Institutes of Health (FNIH) and the National Institutes of Health (NIH), intended to accelerate new gene therapies for patients with rare diseases. RSRT is one…
Post Views: 240 SD METRO Magazine recognized Susan Almon-Pesch along with ten other talented PR and marketing executives in its January 2022 cover story featuring San Diego’s top professionals in the industry. Honoree, Almon-Pesch, is the owner of Market 4 Profit. Founded in San Diego, California in 1999, the marketing and public relations agency serves…
Post Views: 232 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has agreed to acquire the Canadian assets of Teligent Inc. (Teligent) for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. The acquisition marks Hikma’s expansion into Canada and includes a…
Post Views: 268 Novel designer drugs, also called research chemicals or legal highs, still produce physiological and psychological effects, though experts say that they can come with a slew of risks. Synthetic opioids such as fentanyl, for instance, are increasingly cited among the number of opioid-related deaths in the United States, which reached more than…
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |